Inflection Point Acquisition Corp. V

IPEXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

—

$10.23 +4.12%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

$396.9K

#2408 by earnings

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Inflection Point Acquisition Corp. V lists more than one class of stock. Company figures above cover all classes combined.

IPEXR IPEXU

Where these numbers come from

Share counts and financials for Inflection Point Acquisition Corp. V are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.